Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI Biopharma Biotech
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Biopharma Biotech Clinical trials

Biopharma

How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship
Blog September 22, 2025
How Clarivate works towards SDG 3: good health and well-being through antimicrobial stewardship
BioWorld at 35: a legacy of trusted journalism, a future of innovation BioWorld at 35: a legacy of trusted journalism, a future of innovation
Blog September 17, 2025
BioWorld at 35: a legacy of trusted journalism, a future of innovation
How creative design can elevate your healthcare value communication tools How creative design can elevate your healthcare value communication tools
Blog September 12, 2025
How creative design can elevate your healthcare value communication tools
5 key time-saving benefits of AI-driven regulatory intelligence 5 key time-saving benefits of AI-driven regulatory intelligence
Blog September 10, 2025
5 key time-saving benefits of AI-driven regulatory intelligence
Streamlining regulatory compliance with AI-enabled intelligence Streamlining regulatory compliance with AI-enabled intelligence
Blog September 2, 2025
Streamlining regulatory compliance with AI-enabled intelligence
New enrollment data shows health insurance disruption as more volatility approaches New enrollment data shows health insurance disruption as more volatility approaches
Blog July 2, 2025
New enrollment data shows health insurance disruption as more volatility approaches
These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Pharma is placing bigger bets on fewer, more strategic assets/platforms Pharma is placing bigger bets on fewer, more strategic assets/platforms
Blog May 28, 2025
Pharma is placing bigger bets on fewer, more strategic assets/platforms
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
A closer look at four of this year’s Drugs to Watch A closer look at four of this year’s Drugs to Watch
Blog May 6, 2025
A closer look at four of this year’s Drugs to Watch